(Q36829628)

16 August 2017

1 reference

title

Therapeutic options for cutaneous leishmaniasis (English)

1 reference

16 August 2017

Vikram K Mahajan

1

1 reference

PubMed ID

17520466

16 August 2017

Nand Lal Sharma

series ordinal

2

1 reference

16 August 2017

1 January 2007

1 reference

Journal of Dermatological Treatment

16 August 2017

1 reference

16 August 2017

18

1 reference

16 August 2017

2

1 reference

16 August 2017

97-104

1 reference

The psychological impact of cutaneous leishmaniasis.

16 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Leishmaniasis. Currently recommended treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Cardiac effects of sodium stibogluconate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Evaluation of sodium stibogluconate in the treatment of cutaneous leishmaniasis in Syria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

American cutaneous leishmaniasis. Inefficacy of metronidazole in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Leishmaniasis in the United States. A report of ten cases in military personnel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Treatment of cutaneous leishmaniasis with oral itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Cutaneous Leishmaniasis Treated With Metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Failure of metronidazole treatment in Ethiopian mucocutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Rifampin in leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Antidepressants cause lethal disruption of membrane function in the human protozoan parasite Leishmania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Treatment of cutaneous leishmaniasis with ketoconazole cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Dissemination in cutaneous leishmaniasis. 3. Lymph node involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Further trials of nifurtimox in mucocutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Suppression of posttreatment recurrence of experimental visceral Leishmaniasis in T-cell-deficient mice by oral miltefosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Molecular and cellular effects of hexadecylphosphocholine (Miltefosine) in human myeloid leukaemic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Leishmaniasis: new approaches to disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Spraying houses in the Peruvian Andes with lambda-cyhalothrin protects residents against cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

Insecticide impregnated curtains to control domestic transmission of cutaneous leishmaniasis in Venezuela: cluster randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630601159474

10.1080/09546630601159474

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17520466